Ten agent workflows for the R&D Team — gene therapy developer monitoring, CRISPR platform tracking, genomics tool assessment, next-generation sequencing intelligence, gene editing IP landscape, cell therapy manufacturing, base/prime editing advances, epigenetic therapy tracking, spatial genomics innovation, and R&D strategy dashboard — enabling data-driven genomics decisions powered by comprehensive domain intelligence.
AI agent monitors gene therapy company domains to track vector development, clinical programs, manufacturing capabilities, and regulatory pathways across in vivo and ex vivo gene therapy approaches.
AI agent monitors CRISPR technology company domains to track platform developments, new editing modalities, delivery innovations, and clinical applications of gene editing technologies.
AI agent monitors next-generation sequencing company domains to track platform launches, throughput improvements, cost reductions, and new applications — informing sequencing technology investment decisions.
AI agent monitors patent filings and IP developments across gene editing companies to map freedom-to-operate, identify licensing opportunities, and track IP disputes.
AI agent monitors cell therapy CDMO and manufacturing domains to track capacity expansion, process innovations, and cost reduction signals — informing manufacturing strategy for cell and gene therapies.
AI agent tracks next-generation gene editing modalities including base editing and prime editing to monitor clinical progress, platform improvements, and competitive differentiation from traditional CRISPR approaches.
AI agent monitors epigenetic therapy companies to track developments in DNA methylation, histone modification, and chromatin remodeling therapies — an emerging class of precision medicines.
AI agent monitors spatial biology and spatial genomics companies to track technology platforms, new applications, and adoption trends — informing research tool investments and partnership decisions.
AI agent monitors multiomics technology companies to track platform integration, data analysis tools, and clinical applications combining genomics, proteomics, metabolomics, and transcriptomics.
AI agent synthesizes all genomics and CRISPR intelligence into an executive dashboard — providing leadership with real-time visibility into technology evolution, competitive dynamics, and strategic opportunities.
For pricing, subscription options, custom database builds, or enterprise partnerships — contact us below.
Subscribe to the AI Agent Domain Database — continuous access to 102M domains, 20 page types each, quarterly refreshes, and real-time change signals.
Annual subscription includes quarterly data refreshes, change detection alerts, and priority API access.